New York 2025 Session Status: Introduced

A2640 — Relates to requiring prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains if such drug is in tablet or capsule form

Last action — In Assembly Committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Assembly. Introduced January 21, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Prognosis

Not enough signal yet

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

In plain language

Requires prescription drug containers to have detailed labeling for tablets and capsules.

This bill mandates that labels on prescription drug containers include descriptions of the size, shape, color, and imprint of the tablets or capsules. The text of the bill is not available for further details.

Summary

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains if such drug is in tablet or capsule form.

Bill Text

Action History

  1. REPORTED REFERRED TO RULES

  2. REPORTED REFERRED TO CODES

  3. PRINT NUMBER 2640A

  4. AMEND (T) AND RECOMMIT TO HIGHER EDUCATION

  5. REFERRED TO HIGHER EDUCATION

  6. REFERRED TO HIGHER EDUCATION

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does A2640 do?
Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains if such drug is in tablet or capsule form.
Who sponsors A2640?
A2640 is sponsored by Nader Sayegh.
What is the current status of A2640?
This bill has been introduced in the Assembly. Introduced January 21, 2025. It must pass committee before a floor vote.
Where can I track A2640?
Track A2640 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on A2640

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of A2640

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →